Article
Baltimore-Nonsteroidal anti-inflammatory drugs may reduce therisk of prostate cancer, suggests a study completed by Johns Hopkins Hospitalin Baltimore, the National Institute on Aging, and Merck Research Labs.The researchers stress that the findings are suggestive but not definitive.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.